CVM si iatocssead twhi ngfcneiit onrga lnnartspat p.sttiena MCV is demaistrttn vai saxuel caotct,n grnao tantan,rpsl ro alelctrivy avi pc.eantla oacnviaiRtte of MCV scuroc in hte d.mmirsuunespopse
anrOg nrsptlatna npattise rea ta na ceaiednsr rksi fo VMC miennua.op
eh swa reenv egivn iigacrlovcn - i seud htat as a cuel oevr lpttnarsna rencoejti
yWh ouwld itsh not eb cetua lnnsparatt orienctej eilgnda to D?ASR hTe aenrentiic is dle,avtee nda I ees nay saenor yhw ti dwlou be vtdeeeal ynebod rcteneioj
via @sammyj98 via UpToDate:
Universal prophylaxis with valganciclovir or ganciclovir is typically given to patients at risk for cytomegalovirus (CMV) reactivation (eg, seropositive recipients and those with seropositive donors). The duration of therapy often depends on the type of organ transplanted, the risk status of the patient, and individual institutional practice. Some transplant centers prefer to use a pre-emptive approach (eg, routine CMV viral load monitoring within initiation of treatment when reactivation becomes evident) for specific patient populations.
submitted by โamorah(115)
It can be re-accessed by making a purchase.
Purchase your membership here
$279$49eervF g&-;t rule tou eltf ertiulnracv faeulri S-TMP XM lpxhspryaoi t&;-g leru out mosnPycsutei jKdicneo yeiriv lsnaapttnr ubt no /BBWRCC in neiur -&;gt uler uto rattsnnpla itercjoen
engvLai MCV dna lcpitaya aembccmuotiyr as teh iriagnmen two otsp.ion MVC is rome eiklyl ni a rpannltats tptiena.
$279$49